The trademark application SHIFT BIO THE NEXT PARADIGM SHIFT was filed by SHIFTBIO, a corporation established under the laws of the Republic of Korea (the "Applicant"). The application was published for oppositions on July 27, 2022, and it was registered by office on November 3, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Biological preparations comprising exosomes for therapeutic applications, namely, biological preparations for treatment of metabolic and fibrotic disorders, immune diseases, cancer, neurological disorders, ophthalmic diseases, and rare disease.
The mark was filed in class 42 with Biopharmaceutical research and development services related to new drug modalities including exosomes.